+ Watch CVS
on My Watchlist
The Company's current operations are grouped into two businesses: Retail Pharmacy and Pharmacy Benefit Management.
If you like to make money and don't like to lose it, CVS is for you. Get-rich-slowly kind of stock with a very modest valuation.
I'm going to track WAG and CVS here, based on the research in AAII (April 2013: Joint Quality, Value and Momentum).
Buying on the pullback. Low P/E and history of increasing dividend payments make this a winner
good fundamentals, cheap on Book value basis, good profitability
I teach Technology and Society at an unnamed college. (Honest, we have no name.) One of the easiest concepts for my students to grasp is that health care costs rise faster than others because we're willing to pay for it. Pharmacies may not have the potential as developing drugs, but they also don't have the perils. The fundamentals for this company are good. An investment isn't going to make you rich, but it should perform well for a long time.
Not my traditional investment as I'm relying on more growth than anything, but still pays a decent dividend and valuation is okay. They have impressed me with YOY revenue growth and with the baby boomers continuing to age, I see huge growth. It may take a few years, but I have time.
aging population, convenience, promotions
CVS will benefit from the growth of their PBM, Caremark, as well as their brick and mortar from the Baby Boomers retiring with plenty of money to spend on Health Care.
Play on aging population and Obamacare
Strong financials in a retail area that's only going to get larger.
growth on minuteclinic, attracting patients to retail stores, sell more goods
Drug stores have a lot of wind at their backs:- Aging- Insulation from any significant downward price pressure- Switch to generics (profit driver)- Specialty pharmacy services (profit and revenue driver)
S &P 5 star
CVS possesses enormous purchasing power relative to its peers. CVS filled 990 million prescriptions versus 785 million for Walgreen in 2012. CVS will benefit from the soured relationship between Walgreen and Express Scripts. Obamacare will decrease the number of uninsured expanding CVS's market. All of this adds up to market beating returns.
Search Criteria:S&P STARS Ranking: = 5 stars (5 is the highest rank out of 5) +S&P Fair Value Ranking: = 5 (5 = undervalued, 1 = overvalued)
With retiring baby boomers, and the diseases of a country that cannot eat nutritious food to literally save our lives, we're going to see a boom in any healthcare company that sells pills to constant crops of consumers of them.
baby boomers retiring
I am not a fan of the way this company treats their employees. Wether it is the pay, or the fact that they don't provide pens and paper for Pharmacy help. Intuitively, I believe their costs have to be the lowest of anyone else out there.
Anything related to pharmaceutical sales can be expected to grow, and that includes retail pharmacies.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions